Class I histone deacetylases are critical regulators of gene transcription by erasing lysine acetylation. Targeting histone deacetylases using relative non-specific small molecule inhibitors is of major interest in the treatment of cancer, neurological disorders and acquired immune deficiency syndrome. Harnessing the therapeutic potential of histone deacetylase inhibitors requires full knowledge of individual histone deacetylases in vivo. As hematologic malignancies show increased sensitivity towards histone deacetylase inhibitors we targeted deletion of class I Hdac1 and Hdac2 to hematopoietic cell lineages. Here, we show that Hdac1 and Hdac2 together control hematopoietic stem cell homeostasis, in a cell-autonomous fashion. Simultaneous loss of Hdac1 and Hdac2 resulted in loss of hematopoietic stem cells and consequently bone marrow failure. Bone-marrow-specific deletion of Sin3a, a major Hdac1/2 co-repressor, phenocopied loss of Hdac1 and Hdac2 indicating that Sin3a-associated HDAC1/2-activity is essential for hematopoietic stem cell homeostasis. Although Hdac1 and Hdac2 show compensatory and overlapping functions in hematopoiesis, mice expressing mono-allelic Hdac1 or Hdac2 revealed that Hdac1 and Hdac2 contribute differently to the development of specific hematopoietic lineages. 
Introduction
Hematopoiesis, the generation of blood cells, is a multistep differentiation process, which is controlled and maintained by epigenetic mechanisms. Differentiation of pluripotent hematopoietic stem cells (HSC) into lineage-specific progenitors and specialized hematopoietic cell lineages is initiated by external stimuli that induce chromatin modifications which drive and maintain lineage-specific expression programs. 1, 2 The establishment of lineage-specific chromatin modifications is mediated by a host of chromatin-modifying enzymes including Zn 2+ -dependent histone deacetylases (HDAC). While histones were initially identified as HDAC-substrates, many non-histone proteins have also been identified as substrates, indicating that they act beyond chromatin modifications. 3 HDAC are subdivided into three classes of which class I HDAC (HDAC1, 2, 3, 8 and 10) are homologous to yeast Rpd3. [4] [5] [6] To exert their role as transcriptional regulators class I HDAC are directed to genomic regulatory regions through interactions with multi-protein complexes harboring DNA binding proteins. HDAC1 and HDAC2 are primarily found in biochemically distinct repressor complexes, Swi-independent 3 (SIN3), Nucleosome remodeling deacetylase complex (NuRD), Co-repressor of REST (CoREST), Polycomb repressor complex 2 (PRC2) and Mitotic histone deacetylase complex (MiDAC). 4, 7 Class I HDAC have been implicated in tumorigenesis as they are over-expressed in various tumor types and interact with oncogenic fusion proteins and tumor suppressors. Inhibitors of class I HDAC were shown to reduce (tumor) cell proliferation and have entered the clinic in the treatment of hematopoietic malignancies 8 and attracted interest as therapeutics in the treatment of neurological disorders 9 and acquired immune deficiency syndrome. 10 However, patients treated with HDAC inhibitors often develop hematologic side effects. To understand the mechanism of action of these inhibitors, knowledge of the in vivo function of individual HDAC is required. Using mouse models carrying Hdac1 and Hdac2 conditional knock-out alleles, we previously identified a redundant function for Hdac1 and Hdac2 in hematopoiesis. Dual loss of these histone deacetylases throughout the bone marrow resulted in ablation of the megakaryocyte and erythrocyte lineages accompanied by anemia and thrombocytopenia. 11 It did, however, remain unclear whether Hdac1 and Hdac2 have functions in other hematopoietic lineages and whether these functions are cellautonomous or due to a role in non-hematopoietic cells. In addition, it is unclear which of the biochemically distinct Hdac1/2 repressor complexes are involved in epigenetic programming of hematopoietic lineages. Here, using mouse models carrying conditional knock-out alleles for Hdac1, Hdac2 and Sin3a, we showed an intrinsic and overlapping function for Sin3a-associated Hdac1 and Hdac2 in hematopoietic stem cell homeostasis. Moreover, mice expressing only Hdac1 or Hdac2 at levels similar to those in wild-type mice revealed that Hdac1 and Hdac2 contribute differently to the total Hdac1/2 levels required for differentiation of hematopoietic lineages.
Methods

Mice
Mice with conditional Hdac1 and Hdac2 knock-out alleles, such as MxCre;Hdac1 L/L ;Hdac2 L/L , have been described elsewhere. 11, 12 To delete Hdac1 and/or Hdac2 in the hematopoietic system, we crossed the
Western blot analysis
Cells were lysed in RIPA buffer (20 mM Tris, pH7.5, 150 mM sodium chloride, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM EDTA, 0.1% SDS) containing protease inhibitors (Roche), phosphatase inhibitors, 5 μM trichostatin and 1 mM nicotinamide. For western blots 20 μg of protein lysate were incubated with antibodies against either Hdac1 (IMG-337, Imgenex), Hdac2 (SC-7899, Santa Cruz Biotechnology), or γ-tubulin (T6557, Sigma) and horseradish peroxidase-coupled secondary antibodies (Dako). Western blots were stained with enhanced chemiluminescence (Pierce), imaged, and quantified with ChemiDoc software (BioRad).
Methylcellulose colony-forming assays
Bone marrow cells or splenocytes were isolated 8 days after pI;pC injection. To grow myeloid colonies 2x10 4 nucleated cells were cultured with Methocult M3434 (Stem Cell Technologies). To grow B-cell colonies, 5x10 4 nucleated bone marrow cells were cultured with Methocult M3630 (Stem Cell Technologies). Colonies were scored after 10 days.
Competitive bone marrow transfer
Donor bone marrow cells were collected from experimental and wild-type (WT) mice, mixed in a 1:1 ratio and injected into lethally irradiated (2 x 5.5 Gy) recipient mice (n=5 per group). After 8 weeks, bone marrow reconstitution was analyzed by flow cytometry using Ly5.1-PE and Ly5.2-FITC (BD Biosciences) antibodies. Upon successful reconstitution, Cre-recombinase was induced by intraperitoneal injection of 5 x 300 μg pI;pC, every other day. For 3 months, peripheral blood was monitored using Ly5.1-PE and Ly5.2-FITC antibodies. After the experiment, HSC and progenitor populations were analyzed by FACS.
RNA-sequencing of bone marrow hematopoietic stem cells/progenitors
RNA was isolated using Trizol from Lin 
Results
Hdac1 and Hdac2 are essential for early hematopoiesis
To determine the role of Hdac1 and Hdac2 in hematopoietic development we previously developed a mouse model allowing conditional inactivation of Hdac1 and Hdac2 in the bone marrow. 11, 12 In contrast to single deletions, simultaneous deletion of Hdac1 and Hdac2 led to rapid death due to severe anemia and thrombocytopenia, which was associated with a reduction of bone marrow cells. 11, 12 To provide a rationale for the hematopoietic defects in mice lacking both Hdac1 and Hdac2 
;Hdac2
Δ/Δ (DKO)] we analyzed their bone marrow composition. In agreement with our previous results, 11 loss of either Hdac1 or Hdac2 did not affect the number of splenocytes, thymocytes or bone marrow cells, while compound loss of both deacetylases resulted in a dramatic reduction in cellularity of these organs ( Figure  1A , B). The reduction in bone-marrow cells in DKO mice affected all major hematopoietic lineages and was associated with an increase in apoptotic bone marrow cells ( Figure 1C,D) . These findings suggest that Hdac1 and Hdac2 have a critical role early during hematopoiesis. Indeed, hematopoietic progenitors and HSC were almost completely ablated in DKO mice, while their numbers remained normal in MxCre + ;Hdac1 Δ/Δ (Hdac1KO) and Figure 1E ). To exclude that markers used for the identification of early hematopoietic progenitors and HSC were deregulated in cells lacking Hdac1 and Hdac2, we functionally assayed bone marrow cells from WT and DKO mice using in vitro colony assays in semi-solid medium. As indicated in Figure 1F , simultaneous loss of Hdac1 and Hdac2 was incompatible with the outgrowth of myeloid or pre-B-cell colonies, strongly suggesting that Hdac1 and Hdac2 have an essential and overlapping role in HSC homeostasis.
Cell-autonomous function of Hdac1 and Hdac2 in the maintenance of hematopoietic stem cells
Activation of Mx-promoter-driven Cre-recombinase results in deletion of Hdac1 and Hdac2 in hematopoietic and niche-supporting mesenchymal cells. 13 To address whether Hdac1 and Hdac2 have a cell-intrinsic function in HSC or also a function in non-hematopoietic bone marrow cells we performed competitive bone marrow transplantation assays. Non-induced MxCre Figure 2C ). The small remaining fraction of Ly5.2 + cells showed the presence of non-recombined Hdac1 and Hdac2 conditional knock-out alleles ( Figure 2D ), providing further support for an essential role for Hdac1 and Hdac2 in long-term bone marrow reconstitution.
Gene expression analysis using RNA-Seq of sorted progenitors and HSC from pI;pC-treated control and MxCre
L/L mice revealed that only a limited set of genes were significantly (P-value <0.05, logFC >0.58) deregulated upon loss of Hdac1/2 (Online Supplementary Figure S1) . Interestingly, one of the up-regulated genes, Nuclear casein kinase and cyclin-dependent kinase substrate 1 (Nucks1) correlated with the levels of Bax and activated caspase-3, which are indicative of apoptosis.
Moreover, Nucks1 was up-regulated very early during neuronal apoptosis in vitro. 17 In contrast, the survival factor Tumor protein translationally controlled 1 (Tpt1) was downregulated, further suggesting that Hdac1 and Hdac2 may control genes to allow survival of HSC. Dermokine (Dmkn) a gene which is biochemically linked to the Cripto-GRP78 regulatory signal in HSC, 18, 19 was down-regulated in Hdac1/2 -deficient HSC/progenitors suggesting that Hdac1/2 regulates HSC maintenance at least in part by regulating Dmkn expression. In conclusion, these experiments indicate that Hdac1 and Hdac2 collectively maintain HSC in a cell-autonomous manner.
Compensatory expression of Hdac2 in Hdac1-deficient hematopoietic cells
Since simultaneous loss of Hdac1 and Hdac2, in contrast to loss of Hdac1 or Hdac2, did interfere with HSC homeostasis, our findings indicate functional redundancy haematologica | 2014; 99(8) Figure 3A ). These findings indicate that loss of Hdac1 in bone marrow can be counterbalanced by a compensatory up-regulation of Hdac2 protein levels. In contrast, loss of Hdac2 was not associated with an increase in Hdac1 suggesting that Hdac1 may have a more dominant role than Hdac2 in hematopoiesis.
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Hdac1/2 dosage determines normal hematopoiesis
To test this hypothesis we generated mice with monoallelic expression of Hdac1 (MxCre + ;Hdac1
) in the bone marrow. Under these conditions Hdac1 and Hdac2 expression levels were similar to those of wild-type animals which allowed us to compare the contribution of Hdac1 or Hdac2 to independent hematopoietic lineages ( Figure  3A ). Previously, we showed that MxCre + ;Hdac1
mice died within 8-12 days following Cre-recombinase activation, which was associated with severe anemia and thrombocytopenia
11
( Figure  3B) . Surprisingly,
;Hdac2 Δ/Δ mice appeared macroscopically normal and showed normal cellularity of bone marrow, spleen and thymus ( Figure 3C , Online Supplementary Figure  S2 ), indicating that mono-allelic expression of Hdac1, without compensatory Hdac2 up-regulation, in contrast to mono-allelic Hdac2 expression, is sufficient to allow normal erythropoiesis and thrombocyte formation. In summary, these results indicate that normal hematopoiesis is controlled by total levels of Hdac1 and Hdac2 in which Hdac1 plays a more dominant role during erythropoiesis.
Differential effects of mono-allelic Hdac1 or Hdac2 expression on hematopoietic lineages
To investigate the consequences of mono-allelic expression of Hdac1 or Hdac2 in hematopoietic lineages we analyzed bone marrow cellularity and composition in mice as compared to control mice ( Figure 3D ). Colony-formation assays confirmed these findings as the number of pre-B-cell colonies were significantly reduced in animals of both genotypes, while myeloid colony numbers appeared unchanged ( Figure 3E ). Finally, erythroid cell numbers were differently affected as we observed a dramatic reduction in erythropoietic cell numbers only in MxCre
,Hdac2 +/Δ mice ( Figure 3D ), suggesting that the observed anemia is caused by a defect in early erythropoiesis. Overall, these results imply a differential dependency of myeloid, lymphoid and erythroid lineages on 
Critical function for Hdac1 early during erythropoiesis
Defective erythropoiesis often leads to compensatory expansion of hematopoietic tissue outside the bone marrow, a phenomenon known as extramedullary hematopoiesis. 20 Indeed, spleens in MxCre
+/Δ mice were 2-to 3-fold larger than control spleens ( Figure 4A) ; flow cytometry showed that this enlargement was caused by an increase in nucleated erythroid cells (Figure 4B,C) . Colony assays in semi-solid media revealed a significant increase in colony numbers when using MxCre 
,Hdac2
+/Δ mice, as evidenced by the fatal anemia in these mice ( Figure 3B ). In order to identify the cause of ineffective erythropoiesis in MxCre
+/Δ mice, we analyzed the different stages (I-IV) of erythropoiesis using CD71 and Ter119 surface markers ( Figure 4F ). In contrast to mono-allelic Hdac1 expression, mono-allelic expression of Hdac2 resulted in a profound reduction in basophilic (type II) and polychromatic (type III) erythroblasts, while pro-erythroblasts (type I) and orthochromatic erythroblasts (type IV) were only mildly affected ( Figure 4F ). As type IV erythroblasts in our FACS analysis also harbor long-lived enucleated erythrocytes, we conclude that Hdac1 very likely plays a critical function in the transition from type I to type II erythroblasts, the phase in which erythroblasts start to proliferate and expand. In summary, these data reveal a differential requirement for Hdac1 and Hdac2 in hematopoietic cell lineages as mono-allelic Hdac1 or Hdac2 expression is sufficient to drive myeloid differentiation while in B-lymphocytes such levels do not allow normal differentiation ( Figure 3D ). 
Sin3a is essential for hematopoiesis
Our results identified an essential, intrinsic and overlapping function for Hdac1 and Hdac2 in the maintenance of HSC. As Hdac1/Hdac2 heterodimers provide the deacetylase activity of multi-protein transcription repressor complexes, such as Mi-2/NuRD, CoREST and Sin3a, 4 we aimed to pinpoint the biochemical defined Hdac1/2 complex contributing to hematopoietic development and HSC maintenance. We, therefore, inactivated Sin3a in bone marrow using a mouse model carrying Sin3a conditional knock-out alleles 21 and the MxCre transgene. Upon successful deletion of Sin3a in bone marrow, mice became moribund at approximately 14 days after the Cre-recombinase induction ( Figure 5A,B) . Resembling the mice with bone marrow-specific deletion of Hdac1 and Hdac2, MxCre + ;Sin3a Δ/Δ mice displayed features of anemia and internal bleeding (data not shown). Indeed, peripheral blood analysis showed a 4-fold reduction in red blood cells while the number of thrombocytes was reduced 16-fold ( Figure  5C ). Assessment of thymus and spleen revealed a severe decrease in the cellularity of these organs ( Figure 5D ). Interestingly, in contrast to splenocytes, thymocyte numbers were reduced in a Sin3a dosage-dependent manner as a result of apoptosis as evidenced by immunohistochemical staining for activated caspase-3 ( Figure 5D ,E Figure 6A ).
Sin3a has a cell-autonomous function in hematopoietic stem cell maintenance
The overlapping phenotypes in MxCre Figure  6F ). Furthermore, virtually no Sin3A-deficient Ly5.2 + HSC and progenitor cells were present in bone marrow at the end of the experiment ( Figure 6G ). These findings indicate a cell-autonomous role for Sin3a in HSC maintenance. The similarity between the phenotypes observed in MxCre + ;Sin3a
Δ/Δ and DKO mice strongly suggests that Sin3a-associated Hdac1 and Hdac2 play an essential and intrinsic role in HSC homeostasis.
Sin3a is essential for T-and B-lymphocyte development
Since Hdac1 and Hdac2 have overlapping functions in the regulation of committed lineages such as T-and B-lymphocytes, [22] [23] [24] it is possible that Sin3a mediates these functions, although it is unknown whether this is the case. To address this issue we specifically deleted Sin3a in thymocytes and B-lymphocytes using the LckCre 15 and Mb1-Cre transgenic mice.
14 As in a previous study, 25 Figure 7C,D) . As these findings are identical to those resulting from deletion of both Hdac1 and Hdac2 in thymocytes 22 we conclude that Sin3a has an intrinsic role in thymocyte development which is mediated through an interaction with Hdac1 and Hdac2. B-cell-specific loss of Sin3a resulted in an almost complete absence of B-lymphocytes in the bone marrow and spleen ( Figure  7E ). Reduced amounts of pro-B lymphocytes were detected in Mb1Cre;Sin3a Δ/Δ mice, suggesting that deletion of Sin3a at the pro-B-lymphocyte stage resulted in apoptosis ( Figure 7F ). These findings completely mimic the results 24 suggesting that the association of Hdac1 and Hdac2 with the Sin3a complex has an intrinsic place in B-lymphocyte differentiation. Overall, the data presented here indicate an essential role for Sin3a-associated Hdac1 and Hdac2 in HSC homeostasis and lymphocyte development which is consistent with the biochemical data supporting the existence of a Sin3a/Hdac1/2 complex.
Hdac1
Discussion
Using an in vivo mouse model carrying Hdac1 and Hdac2 conditional knock-out alleles we identified a critical, cellautonomous role for Hdac1 and Hdac2 in HSC homeostasis. Simultaneous loss of Hdac1 and Hdac2 resulted in depletion of HSC and early hematopoietic progenitors. Likewise, bone marrow-specific inactivation of Sin3a, a major component of the Sin3a/HDAC1/2-repressor complex, resulted in a phenotype identical to that resulting from loss of Hdac1 and Hdac2, identifying the Sin3a/Hdac1/2 complex as a major cell-autonomous regulator of HSC maintenance. The rapid loss of HSC and progenitors upon ablation of Hdac1/2 or Sin3a may suggest that these cell populations were lost due to induction of apoptosis rather than because of slow exhaustion of the HSC compartment. This is in agreement with previous findings that deletion of Hdac1/2 or Sin3a results in cell cycle arrest and apoptosis. 11, [21] [22] [23] [24] [25] [26] [27] Deregulated expression of genes linked to cell survival and stem cell maintenance, such as Dmkn, Nurcks1 and Tpt1, warrants further investigation to determine whether these genes are direct Hdac1/2 targets.
Previously, other researchers investigated the role of Hdac1/Hdac2-containing NuRD and CoREST complexes in HSC maintenance and hematopoiesis. MxCre-mediated deletion of Chromodomain protein 4 (Chd4), a major component of the NuRD complex, resulted in an acute and rapid expansion of HSC and erythroid progenitors, suggesting that Chd4 is critical for maintaining HSC quiescence. 28 In addition, progenitors of the myeloid and lymphoid lineages were lost upon Chd4 deletion, suggesting that the NuRD complex is critical for the myeloid and lymphoid lineages. Inhibition of lysine demethylase Lsd1 or Rcor1, two major components of the CoREST complex, enhanced the proliferation of granulomonocytic, erythroid and megakaryocytic progenitors but blocked the terminal differentiation of these lineages. 29, 30 These findings illustrate a differential role for the NuRD and CoREST complexes compared to Sin3a repressor complexes in HSC homeostasis. The fact that loss of HSC in the absence of Sin3a is not compensated by NuRD or CoREST complexes provides further support for a critical role for Sin3a/HDAC1/2 in HSC homeostasis. However, these results do not exclude the possibility that loss of Sin3a affects the activity or the composition of NuRD and CoREST complexes.
Consistent with an essential role for Sin3a/Hdac1/2 in HSC homeostasis, members of this complex have been identified as integral components of a network that regulates "stem-cellness" in embryonic stem cells. Hdac1, Hdac2 and Sin3a were found in complex with Nanog, Sox2 and Oct4 in a transcription regulatory complex known as Nanog and Oct4 associated deacetylase (NODE), which regulated Nanog expression. [31] [32] [33] In line with this it was shown that HDAC inhibitors can enhance the formation of induced pluripotent stem cells, probably by derepression of critical pluripotency regulators, including Nanog, Oct4 and Klf4. 34 Alternatively, since Hdac1 was found at predominantly active genes in embryonic stem cells and early thymocytes it is also possible that Hdac1 is required for activation of regulators of self-renewal. 35, 36 Moreover, genetic experiments showed that Sin3a or Sin3a interacting factors, such as Ronin, 37 are essential for the survival of inner cell mass in blastocysts while loss of Sin3a in embryonic stem cells resulted in unresolved DNA damage and apoptosis, suggesting a critical role for Sin3A in embryonic stem cell maintenance. 21, 38 Functional compensation between Hdac1 and Hdac2, as seen in the bone marrow, suggests equality between Hdac1 and Hdac2 function. However, using mouse models with mono-allelic expression of Hdac1 or Hdac2, we showed an inequality between the contributions of Hdac1 and Hdac2 to different hematopoietic lineages. Analysis of the myeloid lineage revealed that mono-allelic loss of Hdac1 or Hdac2 did not affect either myeloid cell numbers or myeloid colony formation, suggesting that in this lineage Hdac1 and Hdac2 fully compensate for each other and therefore contribute equally. In contrast, mono-allelic expression of Hdac1 resulted in impaired erythrocyte development, which was not observed in the presence of mono-allelic Hdac2 expression. These observations suggest a dosage-dependent function for Hdac1/Hdac2 complexes in erythrocyte development in which Hdac1 plays a dominant role. Consistent with this hypothesis, HDAC1 was found to play a critical role in converting the NuRD complex from a repressor to an activator during GATA-1-directed erythroid differentiation. 39 Our analysis suggests that Hdac1 plays a prominent role during early hematopoiesis at the transition of stage II to stage III erythroblasts, which is characterized by a massive proliferative expansion of erythroblasts. Since loss of Chd4, a core component of the NuRD complex, resulted in an identical block during erythrocyte development it is possible that Hdac1 associated with the NuRD complex regulates erythrocyte development. 28 Together these data suggest a model in which Hdac1 and Hdac2 determine hematopoietic lineage formation by acting in a dosage-dependent manner. Which lineage is formed may be dependent on the presence of a particular HDAC complex, which critically regulates expression of lineage "identity" genes in a manner similar to that shown for Dnmt1, an HDAC-interacting DNA methyltransferase. 40, 41 The similarity in dosage-dependent tumor suppression by Dnmt1 and Hdac1/2 22, 42 as well as the observation that HDAC1 deacetylated Dnmt1, strongly suggests a close relation between DNA methylation and histone acetylation in hematopoietic cells. 43 Similar to a dominant role for Hdac1 in erythropoiesis, we recently showed a prominent role for Hdac1 in thymocyte development and tumor suppression. 22 In other cell types such as neurons and oocytes, Hdac2 seemed to play a more dominant role. 12, 44 Since Hdac1 and Hdac2 are simultaneously expressed in most cell types it is very likely that regulation of Hdac1/2 is an important mechanism in controlling the cell-type specific functions of these enzymes. Post-translational modifications are known to regulate Hdac1 and Hdac2 activity and complex formation. [45] [46] [47] [48] In addition, endogenous molecules such as sphingosine-1-phosphate and intermediates of nitrogen and carbon Hdac1, Hdac2 and Sin3a in hematopoiesis haematologica | 2014; 99 (8) metabolism were shown to regulate HDAC activity. 49, 50 Intriguingly, β-hydroxybutyrate, a major source of energy for mammals during prolonged exercise or starvation and a compound structurally related to HDAC inhibitors, was shown to inhibit class I HDAC and conferred protection against oxidative stress. 51 These observations portray an intricate relationship between cellular metabolism, Hdac1/Hdac2 activity and epigenetic changes. Consequently, cellular metabolism may be an important regulator of cell fate and lineage differentiation. Finally, inositol tetraphosphate [Ins (1, 4, 5, 6 )P4] was shown to control HDAC3 complex formation. As the residues involved in binding Ins (1, 4, 5, 6) P4 are conserved in Hdac1 and Hdac2, it was suggested that these enzymes are controlled by the PTEN tumor suppressor. 52 The similarity in PTEN and HDAC1/2 function in dosage-dependent tumor suppression and control of HSC homeostasis could be considered to support this hypothesis. 22, 53, 54 As our data support a model in which Hdac1/2 dosage plays a critical, cell-autonomous role in HSC homeostasis and hematopoietic differentiation it will be interesting to identify the signals that regulate the activity of these ubiquitously expressed nuclear deacetylases and thereby determine cellular identity.
